HK1047243A1 - 預防性和治療性治療鏈球菌感染的方法 - Google Patents
預防性和治療性治療鏈球菌感染的方法Info
- Publication number
- HK1047243A1 HK1047243A1 HK02108859.1A HK02108859A HK1047243A1 HK 1047243 A1 HK1047243 A1 HK 1047243A1 HK 02108859 A HK02108859 A HK 02108859A HK 1047243 A1 HK1047243 A1 HK 1047243A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prophylactic
- therapeutic treatment
- streptococcal infections
- streptococcal
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/257,025 US6017528A (en) | 1997-10-31 | 1999-02-25 | Therapeutic treatment of group A streptococcal infections |
PCT/US1999/004063 WO2000050069A1 (en) | 1999-02-25 | 1999-02-25 | A means for the prophylactic and therapeutic treatment of streptococcal infections |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1047243A1 true HK1047243A1 (zh) | 2003-02-14 |
Family
ID=26795447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02108859.1A HK1047243A1 (zh) | 1999-02-25 | 2002-12-05 | 預防性和治療性治療鏈球菌感染的方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US6017528A (zh) |
EP (1) | EP1162994A4 (zh) |
JP (1) | JP2002537350A (zh) |
KR (1) | KR20020000217A (zh) |
AU (1) | AU2876799A (zh) |
BR (1) | BR9917152A (zh) |
CA (1) | CA2366712A1 (zh) |
HK (1) | HK1047243A1 (zh) |
IN (1) | IN2001DE00791A (zh) |
MX (1) | MXPA01008701A (zh) |
NZ (1) | NZ514260A (zh) |
WO (1) | WO2000050069A1 (zh) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406692B1 (en) | 1997-10-31 | 2002-06-18 | New Horizons Diagnostics Corp | Composition for treatment of an ocular bacterial infection |
US6277399B1 (en) * | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
US6248324B1 (en) | 1997-10-31 | 2001-06-19 | Vincent Fischetti | Bacterial phage associated lysing enzymes for treating dermatological infections |
US6335012B1 (en) | 1997-10-31 | 2002-01-01 | Vincent Fischetti | Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth |
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US6326002B1 (en) | 1997-10-31 | 2001-12-04 | New Horizons Diagnostics Corporation | Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract |
US20030129147A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US20030082110A1 (en) * | 1997-10-31 | 2003-05-01 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US6428784B1 (en) * | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
US6399098B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corp | Composition for treating dental caries caused by streptococcus mutans |
US6399097B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corporation | Composition for treatment of a bacterial infection of the digestive tract |
US6423299B1 (en) | 1997-10-31 | 2002-07-23 | Vincent Fischetti | Composition for treatment of a bacterial infection of an upper respiratory tract |
US6432444B1 (en) * | 1997-10-31 | 2002-08-13 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating dermatological infections |
US6056954A (en) * | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
US6752988B1 (en) * | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
US20020136712A1 (en) * | 1997-10-31 | 2002-09-26 | Fischetti Vincent | Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae |
US20030129146A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | The use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US20020127215A1 (en) * | 1999-09-14 | 2002-09-12 | Lawrence Loomis | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
US7063837B2 (en) * | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
AU2001259205A1 (en) * | 2000-04-28 | 2001-11-12 | New Horizons Diagnostic Corporation | The use of bacterial phage associated lysing enzymes for treating various illnesses |
US6608187B2 (en) | 2000-05-23 | 2003-08-19 | The Rockefeller University | C1 bacteriophage lytic system |
US6395504B1 (en) | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
WO2002102405A1 (en) * | 2000-11-02 | 2002-12-27 | New Horizons Diagnostics Corporation | The use of bacterial phage associated lytic enzymes to prevent food poisoning |
US20040213765A1 (en) * | 2001-07-13 | 2004-10-28 | Vincent Fischetti | Use of bacterial phage associated lytic enzymes to prevent food poisoning |
GB0118009D0 (en) * | 2001-07-24 | 2001-09-19 | Regma Biotechnologies Ltd | Novel preparation |
US6759229B2 (en) * | 2001-12-18 | 2004-07-06 | President & Fellows Of Harvard College | Toxin-phage bacteriocide antibiotic and uses thereof |
AU2003273257A1 (en) * | 2002-08-29 | 2004-03-19 | The Uab Research Foundation | Group b streptococcal phage lysin |
US7569223B2 (en) * | 2004-03-22 | 2009-08-04 | The Rockefeller University | Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions |
CN107189997A (zh) | 2011-04-21 | 2017-09-22 | 洛克菲勒大学 | 用于革兰氏阳性菌检测和治疗的链球菌属细菌噬菌体溶素 |
US9279118B2 (en) | 2011-10-05 | 2016-03-08 | The Rockefeller University | Dimeric bacteriophage lysins |
EP2849782B1 (en) | 2012-05-09 | 2020-03-18 | Contrafect Corporation | Bacteriophage lysin and antibiotic combinations against gram positive bacteria |
CA2872911C (en) | 2012-05-09 | 2023-10-03 | Contrafect Corporation | Biofilm prevention, disruption and treatment with bacteriophage lysin |
KR101723466B1 (ko) * | 2015-10-08 | 2017-04-06 | 주식회사 인트론바이오테크놀로지 | 신규한 스트렙토코커스 이니에 박테리오파지 Str-INP-1 및 이의 스트렙토코커스 이니에 균 증식 억제 용도 |
US10851401B2 (en) | 2016-05-12 | 2020-12-01 | Contrafect Corporation | Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides |
US11064730B2 (en) | 2016-07-11 | 2021-07-20 | Philip Morris Products S.A. | Hydrophobic capsule |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3852424A (en) * | 1957-07-26 | 1974-12-03 | Ciba Geigy Corp | Purified ferrimycin and process for obtaining same |
CA1301645C (en) * | 1986-10-08 | 1992-05-26 | David Bernstein | Method for exposing group a streptococcal antigens and an improved diagnostictest for the identification of group a streptococci |
US5997862A (en) * | 1997-10-31 | 1999-12-07 | New Horizons Diagnostics Corporation | Therapeutic treatment of group A streptococcal infections |
-
1999
- 1999-02-25 WO PCT/US1999/004063 patent/WO2000050069A1/en not_active Application Discontinuation
- 1999-02-25 EP EP99909595A patent/EP1162994A4/en not_active Withdrawn
- 1999-02-25 KR KR1020017010898A patent/KR20020000217A/ko not_active Application Discontinuation
- 1999-02-25 MX MXPA01008701A patent/MXPA01008701A/es not_active Application Discontinuation
- 1999-02-25 JP JP2000600679A patent/JP2002537350A/ja active Pending
- 1999-02-25 BR BR9917152-0A patent/BR9917152A/pt not_active IP Right Cessation
- 1999-02-25 AU AU28767/99A patent/AU2876799A/en not_active Abandoned
- 1999-02-25 IN IN791DE2001 patent/IN2001DE00791A/en unknown
- 1999-02-25 NZ NZ514260A patent/NZ514260A/xx unknown
- 1999-02-25 CA CA002366712A patent/CA2366712A1/en not_active Abandoned
- 1999-02-25 US US09/257,025 patent/US6017528A/en not_active Expired - Fee Related
-
2002
- 2002-12-05 HK HK02108859.1A patent/HK1047243A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US6017528A (en) | 2000-01-25 |
CA2366712A1 (en) | 2000-08-31 |
AU2876799A (en) | 2000-09-14 |
EP1162994A1 (en) | 2001-12-19 |
WO2000050069A1 (en) | 2000-08-31 |
MXPA01008701A (es) | 2003-06-24 |
EP1162994A4 (en) | 2004-12-29 |
BR9917152A (pt) | 2002-11-26 |
KR20020000217A (ko) | 2002-01-05 |
JP2002537350A (ja) | 2002-11-05 |
IN2001DE00791A (zh) | 2007-05-25 |
NZ514260A (en) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1047243A1 (zh) | 預防性和治療性治療鏈球菌感染的方法 | |
IL148641A0 (en) | Topical treatment of streptococcal infections | |
HK1200316A1 (zh) | 治療微泡沫 | |
HK1047888A1 (zh) | 適用於不同的疾病預防及治療性療程的細菌性噬體溶素酶用途 | |
AU715620C (en) | Therapeutic methods and uses | |
AU2798900A (en) | Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections | |
PL339848A1 (en) | Therapeutic agent against hypephosphataemia | |
GB2367010B (en) | Body treatment product | |
GB0001710D0 (en) | Therapeutic treatment | |
GB9922752D0 (en) | Medical devices and treatment and prophylaxis | |
IL146465A0 (en) | Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods | |
IL144115A0 (en) | Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections | |
AU2096002A (en) | Therapeutic treatment | |
HUP0001891A3 (en) | Medicament for the treatment of migraine | |
PL352876A1 (en) | A means for the prophylactic and therapeutic treatment of streptococcal infections | |
TW451686U (en) | Pneumatic massaging device | |
AU1392601A (en) | Prevention and treatment of biomaterial-associated infections | |
IL143795A0 (en) | Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections | |
TW483330U (en) | Pneumatic massaging device | |
GB9911238D0 (en) | Therapeutic use | |
GB9906124D0 (en) | Therapeutic agent | |
GB9924980D0 (en) | Therapeutic treatment | |
GB9901505D0 (en) | Therapeutic treatment | |
GB9911700D0 (en) | A prophylactic and treatment for vaginal infections & STD's | |
TW551176U (en) | Improved structure of pneumatic massage device |